Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




International Approvals: Reclast, Dyloject, Tarceva
Link ID 947
Title International Approvals: Reclast, Dyloject, Tarceva
Url http://www.medscape.com/viewarticle/566114?src=rss
Description Canada has approved a new indication for zoledronic acid 5-mg infusion (Aclasta), the United Kingdom has approved a new formulation of diclofenac sodium injection (Dyloject), and Japan has approved erlotinib tablets. Medscape Medical News
Category Articles > Diabetes and Endocrinology
Keywords
Date Nov 20, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Diabetes and Endocrinology
1. The Altered Adrenal Axis and Treatment With Glucocorticoids During Critical Illness
  Although it is clear that dysfunction of the adrenal axis promotes higher mortality among patients with critical illness, the role of exogenous corticosteroids for these patients remains controversial. The current review examines these issues. Nature Clinical Practice Endocrinology & Metabolism
Category:   Articles > Diabetes and Endocrinology


2. Multiple Genetic Loci Linked to Bone Mineral Density and Fractures
  Two studies released Tuesday report the identification of several genetic variants that influence the risk of osteoporosis and fractures. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


3. Body Weight, Not Diabetes, Linked With Prostate Cancer Death
  Diabetes, rather than weight, increases the risk of all-cause mortality in men being treated for locally advanced prostate cancer. Conversely, obesity, not prevalent diabetes, increases the risk of prostate cancer-specific mortality, researchers report in the September 10th issue of the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


4. Serum Phosphate Linked to Mortality Among CKD Patients Not on Dialysis
  Serum phosphate levels within the high-normal range could be an independent predictor of mortality among people with chronic kidney disease, even those not on dialysis. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


5. Acarbose Improves Insulin Levels in Overweight Women With PCOS
  Acarbose, an alpha-glucosidase inhibitor, improves hyperinsulinemia in overweight women with polycystic ovarian syndrome (PCOS), according to a report in the October issue of Fertility and Sterility. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS